제세동기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Defibrillators Market Growth & Trends:

The global defibrillator market size is expected to reach USD 12.57 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 8.1% from 2024 to 2030. The key drivers for this market include supportive regulatory policies, rising incidences of sudden cardiac arrests, product developments, and rising awareness regarding cardiac conditions. The COVID-19 pandemic, however, gave rise to several challenges such as dampened demand for ICDs, logistical bottlenecks, postponed elective surgeries across the globe, and reduced sales growth.

The demand for ICDs plunged during 2020 as governments in many key markets implemented movement restrictions and hospitals deferred elective procedures. The sales recovered gradually as movement restrictions were eased and elective procedure volume went up. For instance, Abbott reported a decline in demand and sales of its cardiovascular and neuromodulation portfolio in 2020. Abbott attributed the sales decrease to reduced procedure volumes resulting from the pandemic.

The rising demand to develop solutions to improve sudden cardiac arrests response and the need to improve patient outcomes is expected to drive innovation in implantable as well as external defibrillators product segments. Innovation in the implantable defibrillators segments is driven by product advancements in subcutaneous and transvenous devices to increase device safety and efficacy. Integration of digital technologies such as analytics and tracking software is expected to drive the development in the external defibrillators segments. Other emerging technological trends include developments in personal AEDs for use in home settings, improvements in tracking technology for AEDs, the use of drones to deliver devices to care sites, and the use of IoT.

Major market players are focused on launching technologically advanced products and collaborations to enhance their presence. For instance, in July 2020, Zoll Medical Corporation launched a new remote view technology feature on its X Series monitor/defibrillator. This enhanced the existing product portfolio. In 2020, the European Emergency Number Association (EENA) launched a project in collaboration with Everdrone and Schiller to understand and explore the possibilities of using Unmanned Aerial Vehicles (UAVs) for emergency medical deliveries. The AEDs used were provided by Schiller, thus strengthening the company's market presence.

Defibrillators Market Report Highlights:

• North America held the largest revenue share in 2023 due to the advanced healthcare infrastructure, supportive policies driving adoption of public access AEDs, and deeper penetration of the technologically advanced devices
• Asia Pacific is anticipated to register the highest CAGR of 9.3% over the forecast period owing to the high prevalence of cardiovascular diseases in China and India and increasing healthcare expenditure
• The industry participants are focusing on investing in acquisitions, collaborations, product launches, and partnerships to gain a competitive edge in the market
• Some of the leading players in the market are headquartered in Asia such as Asahi Kasei, Nihon Kohden, and Microport, thus contributing to the regional market growth
• Europe held a significant revenue share in 2023 owing to initiatives by key companies and well-established healthcare infrastructure
• For instance, in January 2020, Medtronic received the CE mark for its Cobalt and Crome lineup of defibrillators. This extended the company's cardiac solutions offerings and enabled it to commercialize the products across Europe

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
  • 1.2.1. Information Procurement
• 1.3. Information or Data Analysis
• 1.4. Methodology
• 1.5. Research Scope and Assumptions
• 1.6. Market Formulation & Validation
  • 1.6.1. Country Market: Cagr Calculation
• 1.7. Country Based Segment Share Calculation
• 1.8. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional Insights
• 2.4. Competitive Insights
• 2.5. Defibrillators Market Snapshot
• 2.6. Defibrillators Market Segment Snapshot
• 2.7. Defibrillators Market Competitive Landscape Snapshot

Chapter 3. Defibrillators: Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Defibrillators Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
• 3.4. Impact of COVID-19 on Defibrillators Market

Chapter 4. Defibrillators Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Defibrillators Market: Product Movement Analysis, 2023 & 2030 (USD Million)
• 4.3. Implantable Cardioverter Defibrillators (ICD) by product
  • 4.3.1. Implantable Cardioverter Defibrillators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.2. S-ICD
    • 4.3.2.1. S-ICD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.3. T-ICD
    • 4.3.3.1. T-ICD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Implantable Cardioverter Defibrillators (ICD) by type
  • 4.4.1. Single Chamber
    • 4.4.1.1. Single Chamber Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Dual Chamber
    • 4.4.2.1. Dual Chamber Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. CRT-D
    • 4.4.3.1. CRT-D Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. External Defibrillators
  • 4.5.1. External Defibrillators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Manual ED
    • 4.5.2.1. Manual ED Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Automated ED
    • 4.5.3.1. Automated ED Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Wearable Cardioverter Defibrillators
    • 4.5.4.1. Wearable Cardioverter Defibrillators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Defibrillators Market: End-use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Defibrillators Market: End-use Movement Analysis, 2023 & 2030 (USD Million)
• 5.3. Hospital
  • 5.3.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Pre-hospital
  • 5.4.1. Pre-hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Public Access Market
  • 5.5.1. Public Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Alternate Care Market
  • 5.6.1. Alternate Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Home Healthcare
  • 5.7.1. Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Defibrillators Market: Regional Estimates & Trend Analysis

• 6.1. Defibrillators Market: Regional Movement Analysis, 2023 & 2030
• 6.2. North America
  • 6.2.1. North America Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. Key Country Dynamics
    • 6.2.2.2. Competitive Scenario
    • 6.2.2.3. Prevalence Insights
    • 6.2.2.4. Regulatory Framework
    • 6.2.2.5. Reimbursement Structure
    • 6.2.2.6. U.S. Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Key Country Dynamics
    • 6.2.3.2. Competitive Scenario
    • 6.2.3.3. Prevalence Insights
    • 6.2.3.4. Regulatory Framework
    • 6.2.3.5. Reimbursement Structure
    • 6.2.3.6. Canada Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Competitive Scenario
    • 6.3.2.3. Prevalence Insights
    • 6.3.2.4. Regulatory Framework
    • 6.3.2.5. Reimbursement Structure
    • 6.3.2.6. UK Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Competitive Scenario
    • 6.3.3.3. Prevalence Insights
    • 6.3.3.4. Regulatory Framework
    • 6.3.3.5. Reimbursement Structure
    • 6.3.3.6. Germany Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Competitive Scenario
    • 6.3.4.3. Prevalence Insights
    • 6.3.4.4. Regulatory Framework
    • 6.3.4.5. Reimbursement Structure
    • 6.3.4.6. France Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Key Country Dynamics
    • 6.3.5.2. Competitive Scenario
    • 6.3.5.3. Prevalence Insights
    • 6.3.5.4. Regulatory Framework
    • 6.3.5.5. Reimbursement Structure
    • 6.3.5.6. Italy Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Key Country Dynamics
    • 6.3.6.2. Competitive Scenario
    • 6.3.6.3. Prevalence Insights
    • 6.3.6.4. Regulatory Framework
    • 6.3.6.5. Reimbursement Structure
    • 6.3.6.6. Spain Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Key Country Dynamics
    • 6.3.7.2. Competitive Scenario
    • 6.3.7.3. Prevalence Insights
    • 6.3.7.4. Regulatory Framework
    • 6.3.7.5. Reimbursement Structure
    • 6.3.7.6. Denmark Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Key Country Dynamics
    • 6.3.8.2. Competitive Scenario
    • 6.3.8.3. Prevalence Insights
    • 6.3.8.4. Regulatory Framework
    • 6.3.8.5. Reimbursement Structure
    • 6.3.8.6. Sweden Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Key Country Dynamics
    • 6.3.9.2. Competitive Scenario
    • 6.3.9.3. Prevalence Insights
    • 6.3.9.4. Regulatory Framework
    • 6.3.9.5. Reimbursement Structure
    • 6.3.9.6. Norway Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Prevalence Insights
    • 6.4.2.4. Regulatory Framework
    • 6.4.2.5. Reimbursement Structure
    • 6.4.2.6. Japan Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. China
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Prevalence Insights
    • 6.4.3.4. Regulatory Framework
    • 6.4.3.5. Reimbursement Structure
    • 6.4.3.6. China Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Prevalence Insights
    • 6.4.4.4. Regulatory Framework
    • 6.4.4.5. Reimbursement Structure
    • 6.4.4.6. India Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5. Australia
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Competitive Scenario
    • 6.4.5.3. Prevalence Insights
    • 6.4.5.4. Regulatory Framework
    • 6.4.5.5. Reimbursement Structure
    • 6.4.5.6. Australia Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.6. Thailand
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Competitive Scenario
    • 6.4.6.3. Prevalence Insights
    • 6.4.6.4. Regulatory Framework
    • 6.4.6.5. Reimbursement Structure
    • 6.4.6.6. Thailand Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.7. South Korea
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Competitive Scenario
    • 6.4.7.3. Prevalence Insights
    • 6.4.7.4. Regulatory Framework
    • 6.4.7.5. Reimbursement Structure
    • 6.4.7.6. South Korea Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Prevalence Insights
    • 6.5.2.4. Regulatory Framework
    • 6.5.2.5. Reimbursement Structure
    • 6.5.2.6. Brazil Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Mexico
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Prevalence Insights
    • 6.5.3.4. Regulatory Framework
    • 6.5.3.5. Reimbursement Structure
    • 6.5.3.6. Mexico Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Argentina
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Prevalence Insights
    • 6.5.4.4. Regulatory Framework
    • 6.5.4.5. Reimbursement Structure
    • 6.5.4.6. Argentina Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.6. Middle East & Africa
  • 6.6.1. Middle East & Africa Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Prevalence Insights
    • 6.6.2.4. Regulatory Framework
    • 6.6.2.5. Reimbursement Structure
    • 6.6.2.6. South Africa Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Prevalence Insights
    • 6.6.3.4. Regulatory Framework
    • 6.6.3.5. Reimbursement Structure
    • 6.6.3.6. Saudi Arabia Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Prevalence Insights
    • 6.6.4.4. Regulatory Framework
    • 6.6.4.5. Reimbursement Structure
    • 6.6.4.6. UAE Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Prevalence Insights
    • 6.6.5.4. Regulatory Framework
    • 6.6.5.5. Reimbursement Structure
    • 6.6.5.6. Kuwait Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Company Market Share Analysis, 2023
• 7.3. Strategy Mapping
• 7.4. Company Profiles/Listing
  • 7.4.1. Medtronic
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance (Net Revenue)
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Abbott
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial Performance (Net Revenue)
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. Boston Scientific Corporation
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial Performance (Net Revenue)
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. BIOTRONIK SE & Co. KG
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial Performance (Net Revenue)
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. MicroPort Scientific Corporation
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial Performance (Net Revenue)
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. Koninklijke Philips N.V.
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance (Net Revenue)
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. Stryker
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance (Net Revenue)
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. ZOLL Medical Corporation (Asahi Kasei)
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial Performance (Net Revenue)
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Nihon Kohden Corporation
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial Performance (Net Revenue)
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. Schiller AG
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial Performance (Net Revenue)
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Strategic Initiatives